Drugs & medicalClass II

Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore,…

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.

Read the official notice →
Date
2025-04-30
Country
United States
Brand
Lupin Pharmaceuticals
Product
clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD…
Classification
Class II
Units
USA nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Lupin Pharmaceuticals recalls

  1. 2025-08-06
  2. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mg, 100 Capsules bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,…

    Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide in the USOfficial notice →
  3. 2025-07-30
  4. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC#…

    Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide.Official notice →
  5. 2025-07-23
  6. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc.…

    Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir…

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed nationwide within the United States.Official notice →
  7. 2025-01-08
  8. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,…

    Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.One US distributor in Ohio.Official notice →
  9. 2024-11-27
  10. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02)…

    CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed to 30 wholesalers/distributors who may have further…Official notice →
  11. 2024-09-04
  12. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore,…

    Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.USA nationwide.Official notice →
All 38 Lupin Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2025-04-30
  2. US
    Drugs & medicalClass III

    OurPharma LLC recalls HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd.,…

    Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..

    FDA · DrugOurPharma LLCNationwide in the USAOfficial notice →
  3. US
  4. US
  5. US
  6. US
    Drugs & medicalClass II

    Denver Solutions, LLC DBA Leiters Health recalls Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd,…

    Lack of Assurance of Sterility: Leaking/damaged syringes.

    FDA · DrugDenver Solutions, LLC DBA Leiters HealthNationwide in the U.S.AOfficial notice →
  7. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited,…

    Lack of assurance of sterility. Bacterial contamination detected in some media fill units

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
See all drugs & medical recalls →